PT  - JOURNAL ARTICLE
AU  - Freeman, Sara
ED  - Genant, Harry K.
TI  - Romosozumab Bone Benefits at 1 Year versus Teriparatide in Postmenopausal Women
DP  - 2014 Aug 01
TA  - MD Conference Express
PG  - 17--17
VI  - 14
IP  - 17
4099  - http://mdc.sagepub.com/content/14/17/17.1.short
4100  - http://mdc.sagepub.com/content/14/17/17.1.full
AB  - The investigational drug romosozumab produced significantly greater improvements in volumetric bone mineral density (vBMD) and volumetric bone mineral content (vBMC) compared with both placebo and teriparatide in postmenopausal women with low bone mass in a substudy of an international multicenter randomized Phase 2 trial.